NEW YORK / LONDON (IT BOLTWISE) – Novo Nordisk has cut prices for its drugs Ozempic and Wegovy after reaching an agreement with Donald Trump. This move aims to increase competition with Eli Lilly’s Zepbound and improve affordability for patients. The price reduction could make these important medications easier for many Americans to access.
Today’s daily deals at Amazon! ˗ˋˏ$ˎˊ˗
Novo Nordisk’s recent announcement that it will cut prices for its Ozempic and Wegovy drugs is a significant step in competition with Eli Lilly’s Zepbound. This decision follows an agreement with former US President Donald Trump, who campaigned for lower drug prices in the US. The new prices are intended to improve affordability for patients and make these important medications easier to access.
The price reduction affects both direct consumer pricing and costs for Medicare and Medicaid. While the price for the lowest doses of Ozempic and Wegovy has been reduced to $349 per month, there is a special offer for new cash payers of $199 per month for the first two months. These moves are intended to increase competition with Eli Lilly’s Zepbound, which also sells for $349 per month.
Another aspect of the agreement is the launch of the TrumpRx website, through which patients can purchase the drugs at reduced prices. This platform aims to allow patients to purchase the drugs without insurance for $350 per month, with plans to reduce the cost to $250 per month over the next two years. This could be particularly beneficial for patients with severe obesity, who are expected to have access to the treatments through Medicare with a $50 copay starting in mid-2026.
Reaction to the announcement was mixed. While shares of Novo Nordisk remained stable, Eli Lilly saw a slight decline of 0.2%. Experts see the price reduction as a strategic measure to secure market share and improve access to vital medicines. However, the long-term impact on the market and pricing of other drugs remains to be seen.
Order an Amazon credit card without an annual fee with a credit limit of 2,000 euros!
Bestseller No. 1 ᵃ⤻ᶻ “KI Gadgets”
Bestseller No. 2 ᵃ⤻ᶻ “KI Gadgets”
Bestseller No. 3 ᵃ⤻ᶻ “KI Gadgets”
Bestseller No. 4 ᵃ⤻ᶻ “KI Gadgets”
Bestseller No. 5 ᵃ⤻ᶻ “KI Gadgets”
Please send any additions and information to the editorial team by email to de-info[at]it-boltwise.de. Since we cannot rule out AI hallucinations, which rarely occur with AI-generated news and content, we ask you to contact us via email and inform us in the event of false statements or misinformation. Please don’t forget to include the article headline in the email: “Ozempic price reduction after Trump agreement”.